CHRW
56
-3
SCHW
62
-2
TROW
56
5
BAC
53
3
APD
59
2
TRIP
47
3
RSG
71
3
CCI
31
3
HSIC
56
5
WDC
47
4
TDC
80
4
WY
54
4
HCP
66
8
PFG
45
3
TJX
64
2
INTC
33
-2
HST
49
-9
JPM
69
2
NDAQ
62
2
ORLY
62
2
CHRW
56
-3
SCHW
62
-2
TROW
56
5
BAC
53
3
APD
59
2
TRIP
47
3
RSG
71
3
CCI
31
3
HSIC
56
5
WDC
47
4
TDC
80
4
WY
54
4
HCP
66
8
PFG
45
3
TJX
64
2
INTC
33
-2
HST
49
-9
JPM
69
2
NDAQ
62
2
ORLY
62
2
Financhill
Back

InfuSystems Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Buy
70

INFU
InfuSystems Holdings

Last Price:
9.29
Seasonality Move:
7.82%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
70
InfuSystems Holdings (INFU) is a Buy

Is InfuSystems Holdings a Buy, Sell or Hold?

  • The current InfuSystems Holdings [INFU] share price is $9.33. The Score for INFU is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • INFU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INFU Stock Price Chart

What is InfuSystems Holdings's stock price today?

  • The InfuSystems Holdings share price today is $9.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INFU is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

INFU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 70.51 Buy
Chaikin Money Flow: -22742 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.37 - 8.87) Buy
Bollinger Bands (100): (5.98 - 7.64) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

INFU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.03 Buy
20-day SMA: 7.86 Buy
50-day SMA: 7.13 Buy
200-day SMA: 7.4 Buy
8-day EMA: 8.95 Buy
20-day EMA: 8.23 Buy
50-day EMA: 7.46 Buy
200-day EMA: 7.5 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

InfuSystems Holdings Earnings Growth & INFU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $0.07 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

InfuSystems Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):